Sleep related breathing disturbances can be differentiated in various phenotypes, especially obstructive sleep apnoea, central sleep apnoea and hypoventilation disorders. Central breathing disturbances represent about 10% of the population of sleep apnoea patients. Several underlying diseases predispose to central sleep apnoea, with heart failure with reduced and preserved ejection fraction being the most prevalent comorbidities. Several studies have shown the impact of central sleep apnoea on mortality of heart failure patients. CPAP and oxygen may reduce central breathing disturbances by about 50% and data on long-term outcome are missing. Since its introduction into clinical practice, adaptive servo ventilation has been studied in several cohorts and randomized controlled trials. It normalizes central breathing disturbances, improves oxygen saturation and left ventricular ejection fraction. However, data on long-term outcome are controversial. Therefore, this program will discuss different algorithms of adaptive servo ventilation, the results of cohort studies and randomized controlled trials and discuss current options and future perspectives.
Target Audience
This activity is intended for medical professionals who have a clinical interest in the management of respiratory patients as seen by the following medical specialists: Pulmonologists, Pneumologists, Respirologists, Respiratory Physiotherapists, Respiratory Therapists (Hospital, Home), Thoracic Surgeons, Home Healthcare Providers, Critical Care Medicine Specialists, Internal Medicine Specialists, Primary Care Physicians (General and Family Practitioners), Advanced Practice Nurses, Nurse Practitioners, Physicians Assistants, Managed Care Medical Directors, and other Practitioners and Payers.
Learning Objectives
After completing this activity, the participant should be better able to:
-
Describe the heterogeneity of phenotypes of central sleep apnoea.
-
Discuss the pathophysiology of central sleep apnoea in heart failure.
-
Explain the algorithm of adaptive servoventilation and its differences.
-
Summarize the impact of central sleep apnoea on outcome of heart failure patients.
-
Identify differences in outcomes of large randomized controlled trials and cohort studies.
Faculty
 |
Prof. Dr. med. Winfried J. Randerath |
American Association for Respiratory Care (AARC) Accreditation
AARC Designation Statement
This Non-traditional program has been approved for 1.0 contact hour Continuing Respiratory Care Education (CRCE) credit by the American Association for Respiratory Care; 9425 N. MacArthur Boulevard, Suite 100, Irving TX 75063 Course #191404000.
How to Obtain AARC / CRCE Credit
Attendees are expected to review all academic materials before attempting to apply for credit. Successful completion of this activity will lead to the issuance of a certificate for 1.0 contact hour of CRCE approved continuing education.
To receive credit, please follow these steps:
- Complete the online registration (registration is free).
- Review all of the academic materials provided.
- Click on the CRCE link to apply for credit.
- Complete the online test and/or evaluation. Participants must receive a test score of at least 70% and answer all evaluation questions to receive a certificate.
- Qualified applicants will be provided with an online (printable) CRCE certificate based on their attendance and satisfactory completion of this academic acitivity.
Term Offering
This activity was released on February 2, 2025 and is valid for two years. Requests for credit must be made no later than February 2, 2027.
The above term offering is for the following accreditations: AARC.
Other Allied Healthcare Professional
Participation Statement
Dane Garvin Ltd. has awarded 1.0 Participation Credit(s) for qualified attendees in the enduring activity Adaptive Servoventilation in Central Sleep Apnoea: Current Knowledge and Future Perspectives.
References
Adaptive Servoventilation in Central Sleep Apnoea Current Knowledge And Future Perspectives
